Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Weight-loss drugs like Wegovy face coverage cuts, leaving many patients struggling to afford them.

flag Patients struggle to access popular weight-loss drugs like Wegovy and Zepbound due to inconsistent coverage. flag Despite improved supplies, many employers and insurers are reducing coverage, and Medicare does not cover these drugs for obesity. flag The high cost, often over $200 per month, makes them unaffordable for many without insurance. flag A large portion of the population could benefit from these treatments, but the lack of consistent coverage complicates long-term use and effectiveness.

61 Articles